Impact Factor
2.88
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.10
231 total citations
h5-index
19
h5 depth signal
Cited share
64.3%
72 of 112
Total citations
231
Citation footprint
Metric signal
0.69
External metric anchor
Self-citation
9.1%
21 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
381
United Kingdom
107
Japan
78
Canada
75
Germany
71
Citing Fields of Research
Cardiology
644
Physiology
522
Pharmacology & Toxicology
492
Stem Cell Biology
331
Cell Biology
273
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,298
Articles tracked across the journal lifetime
Indexed publication set
112
72 cited publications
Last 12 months
166
15.1 publications/month
Open access share
4.2%
7 OA publications in the last year
Leading citing country
United States
381 citing publications
Leading citing field
Cardiology
644 citing publications
Latest tracked publication
2 October 2026
10 recent records available
Coverage & Indexing History
v27, 1992-
v27, 1992-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Cardiology
Physiology
Stem Cell Biology
Cell Biology
Broad Categories
Pharmacology
Toxicology
Cardiology
MeSH Descriptors
Pharmacology
Research Design
Toxicology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1016/j.vascn.2026.108576
Open DOI
Integration of safety pharmacology endpoints into toxicology studies - A survey of GLP institutions in China
03
DOI 10.1016/j.vascn.2026.108575
Open DOI
Weight of evidence in safety pharmacology guidance: A case for explicit probabilistic reasoning in the revision of ICH S7A
04
05
DOI 10.1016/j.vascn.2026.108572
Open DOI
Editorial Board
06
DOI 10.1016/j.vascn.2026.108458
Open DOI
hERG potency data in new drug applications submitted to the U.S. Food and Drug Administration between 2008 and 2024
07
DOI 10.1016/j.vascn.2026.108498
Open DOI
The influence of media on toxicity testing using human iPSC-derived cardiomyocytes in monoculture and co-culture models
08
DOI 10.1016/j.vascn.2026.108512
Open DOI
Recording ten-fold larger IKr conductances with automated patch clamping using equimolar Cs+ solutions
09
10
Bibliographical & Catalog Notes
Monthly except Jan., Feb., June & Oct.
Also available online.
Continues: Journal of pharmacological methods.
Vol. 33, no. 2 (APR 1995)19950516 Notice published Printed on acid-free paper